Clinical Decision Support Comprehensive Study by Type (Alerts and Reminders, Clinical Guidelines, Order Sets, Patient Data Reports / Dashboards, Document Templates), Components (Software, Hardware, Service), Approach (Passive, Active) Players and Region - Global Market Outlook to 2026

Clinical Decision Support Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Clinical decision support systems is a system which offers clinicians, patients, staff and other individuals with person-specific information and knowledge, logically filtered and presented at suitable times, to improve health and health care. Clinical decision support systems (CDSS) constitutes a significant field of usage of information technology in healthcare. CDSS is designed to assist clinicians and other healthcare professionals in diagnosis as well as decision-making.
This growth is primarily driven by Growing Concerns about Quality of Care at the National Level and Increasing Demand for Better Cognitive Support for Clinicians.

Globally, a noticeable market trend is evident Advanced IT Systems in Academic Medical Center . Major Players, such as Cerner (United States), Mckesson (United States), Epic Systems (United States), Siemens Healthcare (Germany), Meditech (United States), Philips Healthcare (Royal Philips Electronics) (Netherlands), Wolters Kluwer Health (United States), Agfa-Gevaert Group. (Belgium), Elsevier B.V. (Relx Group) (Netherlands) and IBM (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Growing Concerns about Quality of Care at the National Level
  • Increasing Demand for Better Cognitive Support for Clinicians

Market Trend
  • Advanced IT Systems in Academic Medical Center
  • Rising Prominence and Usage of Big Data and M-health Tools

Restraints
  • Reluctance to Adopt Mobile CDSS
  • High Investments for IT Infrastructure

Opportunities
Rising Adoption of CDSSS in Diagnosis and Management of Chronic Diseases
Challenges
Data Security Concerns Related to Cloud-Based CDSS

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Clinical Decision Support Study Sheds Light on
— The Clinical Decision Support Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Clinical Decision Support industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Clinical Decision Support industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Alerts and Reminders
  • Clinical Guidelines
  • Order Sets
  • Patient Data Reports / Dashboards
  • Document Templates
By Components
  • Software
  • Hardware
  • Service

By Approach
  • Passive
  • Active

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Concerns about Quality of Care at the National Level
      • 3.2.2. Increasing Demand for Better Cognitive Support for Clinicians
    • 3.3. Market Challenges
      • 3.3.1. Data Security Concerns Related to Cloud-Based CDSS
    • 3.4. Market Trends
      • 3.4.1. Advanced IT Systems in Academic Medical Center
      • 3.4.2. Rising Prominence and Usage of Big Data and M-health Tools
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Decision Support, by Type, Components, Approach and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Clinical Decision Support (Value)
      • 5.2.1. Global Clinical Decision Support by: Type (Value)
        • 5.2.1.1. Alerts and Reminders
        • 5.2.1.2. Clinical Guidelines
        • 5.2.1.3. Order Sets
        • 5.2.1.4. Patient Data Reports / Dashboards
        • 5.2.1.5. Document Templates
      • 5.2.2. Global Clinical Decision Support by: Components (Value)
        • 5.2.2.1. Software
        • 5.2.2.2. Hardware
        • 5.2.2.3. Service
      • 5.2.3. Global Clinical Decision Support by: Approach (Value)
        • 5.2.3.1. Passive
        • 5.2.3.2. Active
      • 5.2.4. Global Clinical Decision Support Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Clinical Decision Support (Price)
      • 5.3.1. Global Clinical Decision Support by: Type (Price)
  • 6. Clinical Decision Support: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cerner (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Mckesson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Epic Systems (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Siemens Healthcare (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Meditech (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Philips Healthcare (Royal Philips Electronics) (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Wolters Kluwer Health (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Agfa-Gevaert Group. (Belgium)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Elsevier B.V. (Relx Group) (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. IBM (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clinical Decision Support Sale, by Type, Components, Approach and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Clinical Decision Support (Value)
      • 7.2.1. Global Clinical Decision Support by: Type (Value)
        • 7.2.1.1. Alerts and Reminders
        • 7.2.1.2. Clinical Guidelines
        • 7.2.1.3. Order Sets
        • 7.2.1.4. Patient Data Reports / Dashboards
        • 7.2.1.5. Document Templates
      • 7.2.2. Global Clinical Decision Support by: Components (Value)
        • 7.2.2.1. Software
        • 7.2.2.2. Hardware
        • 7.2.2.3. Service
      • 7.2.3. Global Clinical Decision Support by: Approach (Value)
        • 7.2.3.1. Passive
        • 7.2.3.2. Active
      • 7.2.4. Global Clinical Decision Support Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Clinical Decision Support (Price)
      • 7.3.1. Global Clinical Decision Support by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Decision Support: by Type(USD Million)
  • Table 2. Clinical Decision Support Alerts and Reminders , by Region USD Million (2015-2020)
  • Table 3. Clinical Decision Support Clinical Guidelines , by Region USD Million (2015-2020)
  • Table 4. Clinical Decision Support Order Sets , by Region USD Million (2015-2020)
  • Table 5. Clinical Decision Support Patient Data Reports / Dashboards , by Region USD Million (2015-2020)
  • Table 6. Clinical Decision Support Document Templates , by Region USD Million (2015-2020)
  • Table 7. Clinical Decision Support: by Components(USD Million)
  • Table 8. Clinical Decision Support Software , by Region USD Million (2015-2020)
  • Table 9. Clinical Decision Support Hardware , by Region USD Million (2015-2020)
  • Table 10. Clinical Decision Support Service , by Region USD Million (2015-2020)
  • Table 11. Clinical Decision Support: by Approach(USD Million)
  • Table 12. Clinical Decision Support Passive , by Region USD Million (2015-2020)
  • Table 13. Clinical Decision Support Active , by Region USD Million (2015-2020)
  • Table 14. South America Clinical Decision Support, by Country USD Million (2015-2020)
  • Table 15. South America Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 16. South America Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 17. South America Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 18. Brazil Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 19. Brazil Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 20. Brazil Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 21. Argentina Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 22. Argentina Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 23. Argentina Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 24. Rest of South America Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 25. Rest of South America Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 26. Rest of South America Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 27. Asia Pacific Clinical Decision Support, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 30. Asia Pacific Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 31. China Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 32. China Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 33. China Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 34. Japan Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 35. Japan Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 36. Japan Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 37. India Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 38. India Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 39. India Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 40. South Korea Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 41. South Korea Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 42. South Korea Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 43. Taiwan Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 44. Taiwan Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 45. Taiwan Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 46. Australia Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 47. Australia Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 48. Australia Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 52. Europe Clinical Decision Support, by Country USD Million (2015-2020)
  • Table 53. Europe Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 54. Europe Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 55. Europe Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 56. Germany Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 57. Germany Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 58. Germany Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 59. France Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 60. France Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 61. France Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 62. Italy Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 63. Italy Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 64. Italy Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 65. United Kingdom Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 66. United Kingdom Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 67. United Kingdom Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 68. Netherlands Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 69. Netherlands Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 70. Netherlands Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 71. Rest of Europe Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 73. Rest of Europe Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 74. MEA Clinical Decision Support, by Country USD Million (2015-2020)
  • Table 75. MEA Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 76. MEA Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 77. MEA Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 78. Middle East Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 79. Middle East Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 80. Middle East Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 81. Africa Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 82. Africa Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 83. Africa Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 84. North America Clinical Decision Support, by Country USD Million (2015-2020)
  • Table 85. North America Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 86. North America Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 87. North America Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 88. United States Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 89. United States Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 90. United States Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 91. Canada Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 92. Canada Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 93. Canada Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 94. Mexico Clinical Decision Support, by Type USD Million (2015-2020)
  • Table 95. Mexico Clinical Decision Support, by Components USD Million (2015-2020)
  • Table 96. Mexico Clinical Decision Support, by Approach USD Million (2015-2020)
  • Table 97. Clinical Decision Support: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Clinical Decision Support: by Type(USD Million)
  • Table 109. Clinical Decision Support Alerts and Reminders , by Region USD Million (2021-2026)
  • Table 110. Clinical Decision Support Clinical Guidelines , by Region USD Million (2021-2026)
  • Table 111. Clinical Decision Support Order Sets , by Region USD Million (2021-2026)
  • Table 112. Clinical Decision Support Patient Data Reports / Dashboards , by Region USD Million (2021-2026)
  • Table 113. Clinical Decision Support Document Templates , by Region USD Million (2021-2026)
  • Table 114. Clinical Decision Support: by Components(USD Million)
  • Table 115. Clinical Decision Support Software , by Region USD Million (2021-2026)
  • Table 116. Clinical Decision Support Hardware , by Region USD Million (2021-2026)
  • Table 117. Clinical Decision Support Service , by Region USD Million (2021-2026)
  • Table 118. Clinical Decision Support: by Approach(USD Million)
  • Table 119. Clinical Decision Support Passive , by Region USD Million (2021-2026)
  • Table 120. Clinical Decision Support Active , by Region USD Million (2021-2026)
  • Table 121. South America Clinical Decision Support, by Country USD Million (2021-2026)
  • Table 122. South America Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 123. South America Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 124. South America Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 125. Brazil Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 126. Brazil Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 127. Brazil Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 128. Argentina Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 129. Argentina Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 130. Argentina Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 131. Rest of South America Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 132. Rest of South America Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 133. Rest of South America Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 134. Asia Pacific Clinical Decision Support, by Country USD Million (2021-2026)
  • Table 135. Asia Pacific Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 136. Asia Pacific Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 137. Asia Pacific Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 138. China Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 139. China Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 140. China Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 141. Japan Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 142. Japan Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 143. Japan Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 144. India Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 145. India Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 146. India Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 147. South Korea Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 148. South Korea Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 149. South Korea Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 150. Taiwan Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 151. Taiwan Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 152. Taiwan Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 153. Australia Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 154. Australia Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 155. Australia Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 156. Rest of Asia-Pacific Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 157. Rest of Asia-Pacific Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 158. Rest of Asia-Pacific Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 159. Europe Clinical Decision Support, by Country USD Million (2021-2026)
  • Table 160. Europe Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 161. Europe Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 162. Europe Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 163. Germany Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 164. Germany Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 165. Germany Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 166. France Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 167. France Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 168. France Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 169. Italy Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 170. Italy Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 171. Italy Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 172. United Kingdom Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 173. United Kingdom Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 174. United Kingdom Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 175. Netherlands Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 176. Netherlands Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 177. Netherlands Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 178. Rest of Europe Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 179. Rest of Europe Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 180. Rest of Europe Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 181. MEA Clinical Decision Support, by Country USD Million (2021-2026)
  • Table 182. MEA Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 183. MEA Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 184. MEA Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 185. Middle East Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 186. Middle East Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 187. Middle East Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 188. Africa Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 189. Africa Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 190. Africa Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 191. North America Clinical Decision Support, by Country USD Million (2021-2026)
  • Table 192. North America Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 193. North America Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 194. North America Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 195. United States Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 196. United States Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 197. United States Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 198. Canada Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 199. Canada Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 200. Canada Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 201. Mexico Clinical Decision Support, by Type USD Million (2021-2026)
  • Table 202. Mexico Clinical Decision Support, by Components USD Million (2021-2026)
  • Table 203. Mexico Clinical Decision Support, by Approach USD Million (2021-2026)
  • Table 204. Clinical Decision Support: by Type(USD/Units)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Decision Support: by Type USD Million (2015-2020)
  • Figure 5. Global Clinical Decision Support: by Components USD Million (2015-2020)
  • Figure 6. Global Clinical Decision Support: by Approach USD Million (2015-2020)
  • Figure 7. South America Clinical Decision Support Share (%), by Country
  • Figure 8. Asia Pacific Clinical Decision Support Share (%), by Country
  • Figure 9. Europe Clinical Decision Support Share (%), by Country
  • Figure 10. MEA Clinical Decision Support Share (%), by Country
  • Figure 11. North America Clinical Decision Support Share (%), by Country
  • Figure 12. Global Clinical Decision Support: by Type USD/Units (2015-2020)
  • Figure 13. Global Clinical Decision Support share by Players 2020 (%)
  • Figure 14. Global Clinical Decision Support share by Players (Top 3) 2020(%)
  • Figure 15. Global Clinical Decision Support share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Cerner (United States) Revenue, Net Income and Gross profit
  • Figure 18. Cerner (United States) Revenue: by Geography 2020
  • Figure 19. Mckesson (United States) Revenue, Net Income and Gross profit
  • Figure 20. Mckesson (United States) Revenue: by Geography 2020
  • Figure 21. Epic Systems (United States) Revenue, Net Income and Gross profit
  • Figure 22. Epic Systems (United States) Revenue: by Geography 2020
  • Figure 23. Siemens Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Siemens Healthcare (Germany) Revenue: by Geography 2020
  • Figure 25. Meditech (United States) Revenue, Net Income and Gross profit
  • Figure 26. Meditech (United States) Revenue: by Geography 2020
  • Figure 27. Philips Healthcare (Royal Philips Electronics) (Netherlands) Revenue, Net Income and Gross profit
  • Figure 28. Philips Healthcare (Royal Philips Electronics) (Netherlands) Revenue: by Geography 2020
  • Figure 29. Wolters Kluwer Health (United States) Revenue, Net Income and Gross profit
  • Figure 30. Wolters Kluwer Health (United States) Revenue: by Geography 2020
  • Figure 31. Agfa-Gevaert Group. (Belgium) Revenue, Net Income and Gross profit
  • Figure 32. Agfa-Gevaert Group. (Belgium) Revenue: by Geography 2020
  • Figure 33. Elsevier B.V. (Relx Group) (Netherlands) Revenue, Net Income and Gross profit
  • Figure 34. Elsevier B.V. (Relx Group) (Netherlands) Revenue: by Geography 2020
  • Figure 35. IBM (United States) Revenue, Net Income and Gross profit
  • Figure 36. IBM (United States) Revenue: by Geography 2020
  • Figure 37. Global Clinical Decision Support: by Type USD Million (2021-2026)
  • Figure 38. Global Clinical Decision Support: by Components USD Million (2021-2026)
  • Figure 39. Global Clinical Decision Support: by Approach USD Million (2021-2026)
  • Figure 40. South America Clinical Decision Support Share (%), by Country
  • Figure 41. Asia Pacific Clinical Decision Support Share (%), by Country
  • Figure 42. Europe Clinical Decision Support Share (%), by Country
  • Figure 43. MEA Clinical Decision Support Share (%), by Country
  • Figure 44. North America Clinical Decision Support Share (%), by Country
  • Figure 45. Global Clinical Decision Support: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Cerner (United States)
  • Mckesson (United States)
  • Epic Systems (United States)
  • Siemens Healthcare (Germany)
  • Meditech (United States)
  • Philips Healthcare (Royal Philips Electronics) (Netherlands)
  • Wolters Kluwer Health (United States)
  • Agfa-Gevaert Group. (Belgium)
  • Elsevier B.V. (Relx Group) (Netherlands)
  • IBM (United States)
Additional players considered in the study are as follows:
Allscripts Healthcare Solutions (United States) , Hearst Health (United States)
Select User Access Type

Key Highlights of Report


Nov 2021 225 Pages 70 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Clinical Decision Support market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Clinical Decision Support market are Cerner (United States), Mckesson (United States), Epic Systems (United States), Siemens Healthcare (Germany), Meditech (United States), Philips Healthcare (Royal Philips Electronics) (Netherlands), Wolters Kluwer Health (United States), Agfa-Gevaert Group. (Belgium), Elsevier B.V. (Relx Group) (Netherlands) and IBM (United States), to name a few.

Know More About Global Clinical Decision Support Report?